Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg

NCT01806311 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Candesartan32mg
DRUG: Amlodipine10mg

Sponsor

HanAll BioPharma Co., Ltd.